1
|
Chen M, Lv A, Zhang S, Zheng J, Lin N, Xu L, Huang H. Peripheral blood circular RNA circ-0008102 may serve as a novel clinical biomarker in beta-thalassemia patients. Eur J Pediatr 2024; 183:1367-1379. [PMID: 38165465 PMCID: PMC10950970 DOI: 10.1007/s00431-023-05398-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 12/16/2023] [Accepted: 12/19/2023] [Indexed: 01/03/2024]
Abstract
Circular RNA circ-0008102 has previously been found dysregulated in β-thalassemia (β-thal) in circRNAs microarray (GSE196682 and GSE241141). Our study is aimed at identifying whether circ-0008102 could be a novel biomarker in β-thal. The peripheral blood of pediatric β-thal patients with (n = 39) or without (n = 20) blood transfusion and healthy controls (n = 30) was selected. qRT-PCR, ROC curve analysis, Spearman correlation analysis, and FISH were used to analyze clinical value of circ-0008102. qRT-PCR confirmed that circ-0008102 expression in pediatric β-thal patients without blood transfusion was significantly higher. ROC curves analysis showed that the AUC of circ-0008102 for differentiating patients without blood transfusion from patients with blood transfusion and healthy controls with an AUC of 0.733 and 0.711. Furthermore, circ-0008102 expression was positively correlated with the levels of RBC, HbF, β-globin, and γ-globin mRNA, but was negatively corrected with the levels of HbA and Cr. circ-0008102 was mainly located in the cytoplasm. circ-0008102 could induce the activation of γ-globin and negatively regulate the expression of the five highest-ranking candidate miRNAs (miR-372-3p, miR-329-5p, miR-198, miR-152-5p, and miR-627-3p) in K562 cells. CONCLUSION We demonstrate that peripheral blood upregulated circ-0008102 may serve as a novel clinical biomarker for pediatric β-thal without blood transfusion. WHAT IS KNOWN • CircRNAs are known to be involved in various human diseases, and several circRNAs are regarded as a class of promising blood-based biomarkers for detection of β-thal. • CircRNAs exert biological functions by epigenetic modification and gene expression regulation, and dysregulated circRNAs in β-thal might be involved in the induction of HbF in β-thal. WHAT IS NEW • Peripheral blood circ-0008102 maybe serve as a novel clinical biomarker for detection of pediatric β-thal without blood transfusion. • Circ-0008102 participates in the pathogenesis of β-thal through regulating γ-globin expression, and negatively regulates the expression of miR-372-3p, miR-329-5p, miR-198, miR-152-5p and miR-627-3p.
Collapse
Affiliation(s)
- Meihuan Chen
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China
| | - Aixiang Lv
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China
| | - Siwen Zhang
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China
- The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, 350001, China
| | - Junhao Zheng
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China
- The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, 350001, China
| | - Na Lin
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China.
| | - Liangpu Xu
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China.
| | - Hailong Huang
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou, 350001, China.
- The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, 350001, China.
| |
Collapse
|
2
|
Ineffective erythropoiesis in sickle cell disease: new insights and future implications. Curr Opin Hematol 2021; 28:171-176. [PMID: 33631786 DOI: 10.1097/moh.0000000000000642] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
PURPOSE OF REVIEW Sickle cell disease (SCD) is a hemolytic anemia caused by a point mutation in the β globin gene leading to the expression of an abnormal hemoglobin (HbS) that polymerizes under hypoxic conditions driving red cell sickling. Circulating red cells have been extensively characterized in SCD, as their destruction and removal from peripheral blood are the major contributors to anemia. However, few reports showed cellular abnormalities during erythropoiesis in SCD, suggesting that anemia could also be influenced by defects of central origin. RECENT FINDINGS El Hoss et al. demonstrated ineffective erythropoiesis (IE) in SCD and deciphered the molecular mechanism underlying cell death during the hemoglobin synthesis phase of terminal differentiation. They showed that HbS polymerization induces apoptosis of differentiating erythroblasts and that fetal hemoglobin rescues these cells through its antipolymerization function. SUMMARY IE is the major cause of anemia in β-thalassemia patients, and it is generally surmised that it contributes little to anemia of SCD. Recent reports demonstrate the occurrence of IE in SCD patients and show important alterations in the hematopoietic and erythroid niches, both in SCD patients and in the humanized Townes SCD mouse model. This implies that therapeutic strategies initially designed to improve red cell survival in the circulation of SCD patients would also positively impact erythropoiesis and bone marrow cellularity.
Collapse
|
3
|
Vasseur C, Domingues-Hamdi E, Pakdaman S, Galactéros F, Baudin-Creuza V. Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment. Br J Haematol 2021; 196:183-192. [PMID: 34378186 DOI: 10.1111/bjh.17728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 07/02/2021] [Accepted: 07/12/2021] [Indexed: 11/27/2022]
Abstract
Alpha haemoglobin-stabilising protein (AHSP) is a key chaperone synthesised in red blood cell (RBC) precursors. Many studies have reported AHSP as a potential biomarker of various diseases. AHSP gene expression has been studied in detail, but little is known about AHSP protein levels in RBCs. We investigated the AHSP concentration of RBC lysates from control subjects (n = 10) and patients with sickle cell anaemia (SCA) with (n = 10) and without (n = 12) hydroxycarbamide (HC) treatment, to evaluate the clinical relevance of AHSP in SCA. We developed a sandwich enzyme-linked immunosorbent assay method, with which we were able, for the first time, to determine the mean AHSP concentration in control RBC lysates (0·82 µg/ml). The AHSP concentration (2·23 µg/ml) was significantly higher in untreated patients with the SS genotype than in controls. The AHSP concentration decreased significantly on HC treatment (1·50 µg/ml) but remained significantly higher than that in controls. A strong positive correlation was observed between the AHSP concentration and the α-haemoglobin pool with the three groups of subjects pooled into a single group. Our present findings indicate that AHSP concentration can be considered a candidate biomarker for monitoring HC responses in patients with SCA and suggest a role for AHSP in various RBC diseases.
Collapse
Affiliation(s)
- Corinne Vasseur
- Inserm U955-IMRB Team Pirenne, Univ Paris Est Créteil, Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France
| | - Elisa Domingues-Hamdi
- Inserm U955-IMRB Team Pirenne, Univ Paris Est Créteil, Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France
| | - Sadaf Pakdaman
- Inserm U955-IMRB Team Pirenne, Univ Paris Est Créteil, Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France.,Etablissement Français du Sang (EFS) Ile de France-Mondor, Créteil, France
| | - Frédéric Galactéros
- Inserm U955-IMRB Team Pirenne, Univ Paris Est Créteil, Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France.,Unité des Maladies Génétiques du Globule Rouge, Hôpital Universitaire Henri Mondor (AP-HP), Créteil, France
| | - Véronique Baudin-Creuza
- Inserm U955-IMRB Team Pirenne, Univ Paris Est Créteil, Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France
| |
Collapse
|
4
|
Chen L, Liang L, Liao S, Huang Y, Liang L, Li Y. Compound heterozygotes of Hb Constant Spring and Hb Stanleyville II in HbE/β 0-thalassemia. Clin Chem Lab Med 2021; 59:e374-e376. [PMID: 33823095 DOI: 10.1515/cclm-2020-1336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Accepted: 03/29/2021] [Indexed: 11/15/2022]
Affiliation(s)
- Li Chen
- Department of Clinical Laboratory, People's Hospital of Baise City, Baise, Guangxi Zhuang Autonomous Region, P.R. China
| | - Linhui Liang
- Department of Clinical Laboratory, People's Hospital of Baise City, Baise, Guangxi Zhuang Autonomous Region, P.R. China
| | - Shuzhen Liao
- Department of Clinical Laboratory, People's Hospital of Baise City, Baise, Guangxi Zhuang Autonomous Region, P.R. China
| | - Yan Huang
- Department of Hematology and Rheumatology, People's Hospital of Baise City, Baise, Guangxi Zhuang Autonomous Region, P.R. China
| | - Liang Liang
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, P.R. China
| | - Youqiong Li
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, P.R. China
| |
Collapse
|
5
|
Domingues‐Hamdi E, Vasseur C, Pakdaman S, Moutereau S, Habibi A, Bartolucci P, Galactéros F, Baudin‐Creuza V. Hydroxycarbamide decreases the free alpha-hemoglobin pool in red blood cells of adult patients with sickle cell anemia. Am J Hematol 2020; 95:E302-E305. [PMID: 32720721 DOI: 10.1002/ajh.25947] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 07/23/2020] [Accepted: 07/24/2020] [Indexed: 12/18/2022]
Affiliation(s)
- Elisa Domingues‐Hamdi
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
| | - Corinne Vasseur
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
| | - Sadaf Pakdaman
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
- Etablissement Français du Sang (EFS) Créteil France
| | - Stéphane Moutereau
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
- Département de Biochimie‐Biologie Moléculaire, Pharmacologie, Génétique Médicale AP‐HP, Hôpitaux Universitaires Henri Mondor Créteil France
| | - Anoosha Habibi
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
- Unité des Maladies Génétiques du Globule Rouge Hôpital Universitaire Henri Mondor (AP‐HP) Créteil France
| | - Pablo Bartolucci
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
- Unité des Maladies Génétiques du Globule Rouge Hôpital Universitaire Henri Mondor (AP‐HP) Créteil France
| | - Frédéric Galactéros
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
- Unité des Maladies Génétiques du Globule Rouge Hôpital Universitaire Henri Mondor (AP‐HP) Créteil France
| | - Véronique Baudin‐Creuza
- Inserm U955‐ IMRB, Team « Transfusion et Maladies du Globule Rouge » Université Paris Est Créteil Créteil France
- Laboratory of Excellence GR‐Ex Paris France
| |
Collapse
|
6
|
Liu S, Huang LY, Jiang F, Sun XF, Li DZ. Complex interactions between thalassemia defective alleles compromise screening and cause severe anemia in a Chinese family. Int J Lab Hematol 2018; 40:e55-e58. [DOI: 10.1111/ijlh.12811] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2018] [Accepted: 02/27/2018] [Indexed: 11/26/2022]
Affiliation(s)
- S. Liu
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| | - L.-Y. Huang
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| | - F. Jiang
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| | - X.-F. Sun
- Key Laboratory for Major Obstetric Diseases of Guangdong Province; The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou Guangdong China
| | - D.-Z. Li
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| |
Collapse
|
7
|
Huang LY, Li DZ. α-Haemoglobin pool measurement: a useful biomarker for evaluation of β-thalassaemia intermedia? Br J Haematol 2017; 183:673-674. [PMID: 29082517 DOI: 10.1111/bjh.15008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Lv-Yin Huang
- Guangzhou Women and Children Medical Centre affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Dong-Zhi Li
- Guangzhou Women and Children Medical Centre affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China
| |
Collapse
|
8
|
Vasseur C, Galactéros F, Baudin-Creuza V. α-Haemoglobin pool measurement: a useful biomarker for evaluation of β-thalassaemia intermedia? - response to Huang and Li. Br J Haematol 2017; 183:671-673. [PMID: 29076137 DOI: 10.1111/bjh.15007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Corinne Vasseur
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2 : Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC), Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France
| | - Frédéric Galactéros
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2 : Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC), Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France.,French Sickle Cell Referral Center, Groupe Hospitalier Henri Mondor-Albert Chenevier, APHP, Créteil, France
| | - Véronique Baudin-Creuza
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2 : Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC), Créteil, France.,Laboratory of Excellence GR-Ex, Paris, France
| |
Collapse
|
9
|
Vasseur C, Domingues-Hamdi E, Pakdaman S, Barau C, Pissard S, Le Corvoisier P, Pirenne F, Galactéros F, Baudin-Creuza V. Elevated soluble α-hemoglobin pool in sickle cell anemia. Am J Hematol 2017. [PMID: 28646539 DOI: 10.1002/ajh.24835] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Corinne Vasseur
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
| | - Elisa Domingues-Hamdi
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
| | - Sadaf Pakdaman
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
- Etablissement Français du Sang, Île-de-France Mondor; 51 av. du Maréchal de Lattre de Tassigny, Créteil
| | - Caroline Barau
- Plateforme de Ressources Biologiques, Hôpital Universitaire Henri Mondor Assistance Publique Hôpitaux de Paris (AP-HP); Créteil
| | - Serge Pissard
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
- Laboratoire de génétique, Hôpital Universitaire Henri Mondor (AP-HP); Créteil
| | - Philippe Le Corvoisier
- Inserm, Centre d'Investigation Clinique 1430, Hôpital Universitaire Henri Mondor (AP-HP); Créteil
| | - France Pirenne
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
- Etablissement Français du Sang, Île-de-France Mondor; 51 av. du Maréchal de Lattre de Tassigny, Créteil
| | - Frédéric Galactéros
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
- French Sickle Cell Referral Center, Hôpital Universitaire Henri Mondor (AP-HP); Créteil France
| | - Véronique Baudin-Creuza
- Institut National de la Santé et de la Recherche Médicale (Inserm)-U955, équipe 2: Transfusion et Maladies du Globule Rouge, Institut Mondor de Recherche Biomédicale (IMRB), Université de Paris Est Créteil (UPEC); Créteil
- Laboratory of Excellence GR-Ex; Paris
| |
Collapse
|